Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Avanzanite Bioscience Secures €32m Series a Investment From Mvm Partners

Summary by Mid Florida Newspapers
AMSTERDAM--(BUSINESS WIRE)--Nov 18, 2025-

2 Articles

Mid Florida NewspapersMid Florida Newspapers
Center

Avanzanite Bioscience Secures €32m Series a Investment From Mvm Partners

AMSTERDAM--(BUSINESS WIRE)--Nov 18, 2025-

Read Full Article
european-biotechnology.comeuropean-biotechnology.com

Avanzanite secures €32m Series A funding - European Biotechnology Magazine

Dutch Avanzanite Biosciences NV has secured €32 m in a Series A financing round from MVM Partners to scale orphan drug commercialisation across Europe. Dutch Avanzanite Biosciences NV has secured €32 m in a Series A financing round from MVM Partners to scale orphan drug commercialisation across Europe.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Mid Florida Newspapers broke the news in on Tuesday, November 18, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Netherlands icon

Netherlands

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal